Your friendly neighbourhood nephrologist. Vasculitis epi research @UofGlasgow. Likes #rstats, french horn and Batman.
Joined September 2013
- Tweets520
- Following998
- Followers458
- Likes1.5K
Matthew Rutherford retweeted
Thanks to @ISNkidneycare for supporting our ongoing partnership between 🏴 and 🇲🇼. Here’s to many more fruitful years of friendship and collaboration @GlasgowTx @NHSGGC @ScotlandMalawi
Matthew Rutherford retweeted
1/ New thread on recently published @CKJsocial paper by @luisloureiro4 using target trial emulation to assess impact of arteriovenous fistula 🩸 formation on kidney function decline 📉
Link 👉 doi.org/10.1093/ckj/sfae345
🧵by @richard_shemilt
Matthew Rutherford retweeted
Karl's defense of his PhD thesis was really great today, and he did a fantastic job. There was an interesting and very good discussion with the opponent, Prof. Luqmani. Thank you very much. @Vasculitis_Lund
Matthew Rutherford retweeted
I had the pleasure of commenting on this excellent AAV subclassification study with @AKronbichler ✨ published in @TheLancetRheum.
By the way, this is my first paper with my new affiliation, and it comes just in time for my birthday! 😌
@ynptweets
Happy 5th Anniversary to @TheLancetRheum! We were asked to comment on an amazing @fairvasc study (thelancet.com/journals/lanrh…) subclassifying patients with AAV. Please see the comment by @ilayberke and myself (thelancet.com/journals/lanrh…) on this landmark study!
Matthew Rutherford retweeted
Karl Gisslander et al. identified 5 clusters of AAV, 3 of which characterized by kidney involvement. Compared with clinical diagnosis or ANCA status, cluster-based models showed improved predictive power for both patient and kidney survival. @fairvasc @TheLancetRheum
Matthew Rutherford retweeted
Happy and proud to announce that our recent paper on clusters in ANCA-associated vasculitis (AAV) was published yesterday in The Lancet Rheumatology. Using an unprecedented large cohort of 3,868 patients, we confirmed that AAV is not merely a binary construct! @fairvasc
Matthew Rutherford retweeted
NEW RESEARCH—Model-based clustering of a federated international cohort produces a data-driven subclassification of ANCA-associated #vasculitis that exhibits higher predictive value than current approaches for key outcomes thelancet.com/journals/lanrh… @fairvasc @Vasculitis_Lund
Matthew Rutherford retweeted
Important new study from @fairvasc @Vasculitis_Lund @Vasculitis_HL @kiplet69 and many others re-defining AAV subtypes by using close to 4,000 patients with GPA and MPA! @TheLancetRheum
NEW RESEARCH—Model-based clustering of a federated international cohort produces a data-driven subclassification of ANCA-associated #vasculitis that exhibits higher predictive value than current approaches for key outcomes thelancet.com/journals/lanrh… @fairvasc @Vasculitis_Lund
Matthew Rutherford retweeted
Happy 5th Anniversary to @TheLancetRheum! We were asked to comment on an amazing @fairvasc study (thelancet.com/journals/lanrh…) subclassifying patients with AAV. Please see the comment by @ilayberke and myself (thelancet.com/journals/lanrh…) on this landmark study!
Matthew Rutherford retweeted
A big thank you for @RCSEd, was honoured to receive the Syme medal for work supporting my PhD thesis.
Couldn’t have achieved this without everyone’s mentorship and support, particularly @ewenharrison @EeHRN, the @GlobalSurg community and family
1/
Matthew Rutherford retweeted
@cheekaycheung highlighting the dilemma for lupus nephritis, how aggressively to treat proliferative disease. With an increasing menu of treatments we need head to head experimental medicine trials and better bio markers to predict who will respond #ukkw2024
Matthew Rutherford retweeted
Busy week ahead presenting our results at #UKKW2024 & #INS24 . Manuscript almost ready for submission too.
Thanks all who participated!
@kidney_boy @hswapnil @nkf
Matthew Rutherford retweeted
Great day for the lab and especially for the 2 new @Monash_FMNHS PhD graduands - now graduates! @LaniShochet and @nephrologista. High quality theses from outstanding contributors.
Matthew Rutherford retweeted
Delighted our paper on creating a computable phenotype for relapse in ANCA vasculitis is now online. Thanks to all collaborators. Next step = external validation! @THKC1 @itsArthurWhite @CHeDS_ie @louisaslett @nephmatt @ConorJudge5 @IrishVasculitis rmdopen.bmj.com/content/10/2… – at Dublin City, Ireland
Matthew Rutherford retweeted
It's been a wonderful 21st International Vasculitis Workshop in Barcelona @VasculitisBCN24
And the big news: in 2026 - the 22nd Workshop will be hosted by @anzvasc in Melbourne!
We are excited and will do everything we can to host a great interactive workshop. See you in 2026!
Matthew Rutherford retweeted
Systematic reviews and meta-analyses are not the highest level of evidence
Matthew Rutherford retweeted
Emotional handing of the baton to @anzvasc Richard Kitching, Catherine Hill and Vicky Quincy. The next #vasculitis workshop will be in @Melbourne! Feb 2026.
Matthew Rutherford retweeted
New model of murine #ANCA associated vasculitis: optimization of the immune stimuli used allows to cover more phenotype of the #AAV disease. Dr. C. Jennette #vasculitisBCN2024
